D

Divi's Laboratories Ltd

Labs & Life Sciences Services

LARGECAP

Labs & Life Sciences Services

Live Performance vs 

This is a tool to communicate factual return information and should not be seen as an advertisement or promotion

Analyst Ratings and Key Metrics

Based on 22 analysts offering recommendations for Divi's Laboratories Ltd

32%

Buy

32%

Hold

36%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio90.1551.91
PB Ratio10.636.64
Dividend Yield0.55%0.47%

Understand what these metrics mean. 

About the company

D

Divi's Laboratories Ltd

Divi's Laboratories Limited is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs) and Intermediates. Its products include Generic APIs, Intermediates, Peptide Building Blocks and Carotenoids.

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions